RxDoctor Payments Data

Matthew Thoms

Physician Assistant · Enid, OKNPI 1710974506

Payments from drug & device makers

$2,193in general payments, 2019–2025

Across 118 payments — averaging $18.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$735
  • Merck$452
  • AstraZeneca$364
  • Kestra Medical Technology Services, Inc.$105
  • Pfizer$73
  • Actelion Pharmaceuticals US, Inc.$66
  • plus $399 from 11 others

What the payments were for

  • Food & beverage$2,193100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,193 in reported general payments places this provider in the 80th percentile of 1,491 physician assistant providers in Oklahoma.

See all physician assistant providers in Oklahoma

Medicare billing

Part B allowed, 2024
$48,557
Medicare patients
375
Services billed
646

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban309$262,500
EntrestoSacubitril/Valsartan86$78,133
XareltoRivaroxaban94$76,935
FarxigaDapagliflozin Propanediol110$75,157
Repatha PushtronexEvolocumab68$64,473
Repatha SureclickEvolocumab43$39,351
Praluent PenAlirocumab31$18,442
JardianceEmpagliflozin19$13,336
OzempicSemaglutide13$11,991
Rosuvastatin Calcium367$7,745
Metoprolol Succinate329$4,782
Nebivolol Hcl88$4,612
Bumetanide75$2,908
Clonidine16$2,743
Losartan Potassium174$2,466

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$73$262,500309 claims
NovartisEntresto$42$78,13386 claims
Johnson & JohnsonXarelto$48$76,93594 claims
AstraZenecaFarxiga$364$75,157110 claims
Boehringer IngelheimJardiance$34$13,33619 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,491 physician assistant providers in Oklahoma.

Other physician assistant in Enid

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →